カテゴリ： Allied Market Research, 世界, 医療/バイオ

組織内照射療法のグローバル市場（2021〜2031）：シード、アプリケータ・アフターローダー、電気式組織内照射療法

■ 英語タイトル：Brachytherapy Market By Product Type (Seeds, Applicators and Afterloaders, Electronic Brachytherapy), By Technique (High Dose Rate (HDR), Low Dose Rate (LDR)), By Application (Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MA105）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MA105
■ 発行日：2022年12月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：218
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[組織内照射療法のグローバル市場（2021〜2031）：シード、アプリケータ・アフターローダー、電気式組織内照射療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本調査レポートによると、2021年に826.04百万ドルであった世界の組織内照射療法市場規模が、2031年までに16億ドルに達し、2022年から2031年の間に年平均7.1%で成長すると予測されています。本書は、組織内照射療法の世界市場について調査し、市場動向や今後の展望をまとめた資料です。イントロダクション、エグゼクティブサマリー、市場概要、製品別（シード、アプリケータ・アフターローダー、電気式組織内照射療法）分析、技術別（高線量率（HDR）、低線量率（LDR））分析、用途別（婦人科系がん、前立腺がん、乳がん、その他）分析、エンドユーザー別（病院、専門クリニック、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況、企業情報など、以下の構成で掲載しています。本書内には、Argon Medical Devices, Inc.、Eckert & Ziegler BEBIG、Elekta AB、iCAD, Inc.、Siemens AG、isoray medical, inc.、Merit Medical Systems, Inc.、Theragenics Corporation、IsoAid、Carl Zeiss AGなど、主な参入企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の組織内照射療法市場規模：製品別
- シードの市場規模
- アプリケータ・アフターローダーの市場規模
- 電気式組織内照射療法の市場規模
・世界の組織内照射療法市場規模：技術別
- 高線量率（HDR）における市場規模
- 低線量率（LDR）における市場規模
・世界の組織内照射療法市場規模：用途別
- 婦人科系がんにおける市場規模
- 前立腺がんにおける市場規模
- 乳がんにおける市場規模
- その他における市場規模
・世界の組織内照射療法市場規模：エンドユーザー別
- 病院における市場規模
- 専門クリニックにおける市場規模
- その他における市場規模
・世界の組織内照射療法市場規模：地域別
- 北米の組織内照射療法市場規模
- ヨーロッパの組織内照射療法市場規模
- アジア太平洋の組織内照射療法市場規模
- 中南米・中東・アフリカの組織内照射療法市場規模
・競争状況
・企業情報

組織内照射療法市場は、2021年に8億2,604万ドル、2031年には16億3,174万ドルに達すると予測され、2022年から2031年までのCAGRは7.1%となる見込みです。
組織内照射療法は、患者の体内の腫瘍の近くに放射性物質を置く方法です。放射性物質が放射線を照射することでがん細胞を破壊し、分裂や増殖を阻止します。この方法は内部放射線療法とも呼ばれます。

組織内照射療法は、乳がん、子宮頸がん、前立腺がん、眼がんなど、さまざまながんの治療に用いられます。組織内照射療法は一度に大量の放射線を安全に照射することができます。そのため、治療期間が短縮され、がんの再発リスクも低くなります。組織内照射療法による治療時間の短縮は、がんの治療にとってより特別で重要なものとなっています。
組織内照射療法市場の成長を促進する主な要因としては、組織内照射療法における技術進歩の上昇、世界人口における前立腺がん、乳がん、子宮頸がんなどの有病率の急増などが挙げられます。例えば、米国がん協会によると、2021年に米国で新たに190万人ががんと診断され、608,570人ががんで死亡したと推定されています。この報告書によると、2021年に米国で新たに発生した女性の乳がんは281,550人、子宮頸がんは14,480人、結腸・直腸がんは149,500人、子宮体がんは66,570人と推定されています。世界保健機関（WHO）の報告書（2021年）によると、毎年約40万人の子供ががんに罹患しています。全体的ながん罹患率、つまり新たながんの発生率は、女性と子供でわずかに上昇し続けており、それがさらに組織内照射療法市場の成長を後押ししています。

加えて、最小侵襲手術の需要の増加、早期段階でのがん治療に関する意識の高まり、この手術における腫瘍への放射線の正確かつ正確な照射が、組織内照射療法の採用を促進し、組織内照射療法市場の成長を牽引しています。
しかし、組織内照射療法のコストが高いこと、放射線被曝に伴う健康リスクや合併症が組織内照射療法市場の成長を妨げると予想されています。逆に、発展途上国における満たされていない医療需要と新興経済圏における有利なビジネスチャンスは、将来的に組織内照射療法機器メーカーに絶大なビジネスチャンスをもたらすと期待されています。
さらに、遺伝性がんの増加、副作用を軽減するための先進的な組織内照射療法の研究増加により、ヘルスケア事業が成長すると予測され、組織内照射療法市場の成長を後押ししています。さらに、がん治療のために組織内照射療法を提供する病院や専門クリニックの増加、組織内照射療法の使用に関する意識の高まりが、インドや中国のような発展途上国における組織内照射療法市場の成長を後押ししています。このため、予測期間中に主要企業が市場に投資する有益な機会が提供されると予想されます。
さらに、効果的な組織内照射療法製品の発見と開発のための研究開発投資の増加、先進国における資本収入の大幅な増加、主要企業が採用する製品の発売、提携、合併、買収などの主要戦略の急増が、組織内照射療法市場の成長を促進します。

例えば、2021年4月、Siemens Healthineers AGは、Varian Medical Systems, Incの買収を成功裏に完了したと発表しました。Varian社とSiemens Healthineers社は、世界的に増加するがん罹患率に対抗するため、個別化されたデータ主導の診断と精密がん治療に対するニーズの高まりに対応していきます。両社の統合により、画像診断、検査診断、人工知能、治療というユニークで高度に統合されたポートフォリオが構築され、世界的ながんとの闘いのために、価値創造の大きな可能性が生まれます。この買収は、Siemens Healthineersの戦略のアップグレード段階に完全に合致しています。

組織内照射療法市場は、製品タイプ、技術、用途、エンドユーザー、地域によって区分されます。製品タイプ別では、市場はシード、アプリケータ＆アフターローダ、電子組織内照射療法に分類されます。技術別では、市場は高線量率（HDR）、低線量率（LDR）に分類されます。用途別では、婦人科がん、前立腺がん、乳がん、その他。エンドユーザー別では、病院、専門クリニック、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（中国、日本、オーストラリア、インド、韓国、その他のアジア太平洋地域）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA地域）に市場を分けて分析しています。

本レポートに掲載されている主要企業は、Argon Medical、Carl Zeiss AG、Eckert & Ziegler BEBIG、Elekta AB、Icad, Inc、Isoaid、Isoray Medical, Inc、Merit Medical Systems, Inc、Siemens AG、Theragenics Corporationです。

ステークホルダーにとっての主なメリット
・本レポートは、2021年から2031年までの組織内照射療法市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、組織内照射療法市場の有力な機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・組織内照射療法市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解します。
・地域別および世界別の組織内照射療法市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品タイプ別
シード
アプリケーター＆アフターローダー
電子組織内照射療法

技術別
高線量率（HDR）
低線量率（LDR）

エンドユーザー別
病院
専門クリニック
その他

用途別
婦人科がん
前立腺がん
乳がん
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Argon Medical Devices, Inc.
Eckert & Ziegler BEBIG
Elekta AB
iCAD, Inc.
Siemens AG
isoray medical, inc.
Merit Medical Systems, Inc.
Theragenics Corporation
IsoAid
Carl Zeiss AG

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of cancer
3.4.1.2. Increase in geriatric population

3.4.2. Restraints
3.4.2.1. Health risks and complications associated with brachytherapy

3.4.3. Opportunities
3.4.3.1. High growth potential in developing economies

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BRACHYTHERAPY MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Seeds
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Applicators and Afterloaders
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Electronic Brachytherapy
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: BRACHYTHERAPY MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. High Dose Rate (HDR)
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Low Dose Rate (LDR)
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: BRACHYTHERAPY MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Gynecological Cancer
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Prostate Cancer
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Breast Cancer
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Others
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: BRACHYTHERAPY MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Specialty Clinics
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: BRACHYTHERAPY MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product Type
8.2.6.1.3. Market size and forecast, by Technique
8.2.6.1.4. Market size and forecast, by Application
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product Type
8.2.6.2.3. Market size and forecast, by Technique
8.2.6.2.4. Market size and forecast, by Application
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product Type
8.2.6.3.3. Market size and forecast, by Technique
8.2.6.3.4. Market size and forecast, by Application
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product Type
8.3.6.1.3. Market size and forecast, by Technique
8.3.6.1.4. Market size and forecast, by Application
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product Type
8.3.6.2.3. Market size and forecast, by Technique
8.3.6.2.4. Market size and forecast, by Application
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product Type
8.3.6.3.3. Market size and forecast, by Technique
8.3.6.3.4. Market size and forecast, by Application
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product Type
8.3.6.4.3. Market size and forecast, by Technique
8.3.6.4.4. Market size and forecast, by Application
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product Type
8.3.6.5.3. Market size and forecast, by Technique
8.3.6.5.4. Market size and forecast, by Application
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product Type
8.3.6.6.3. Market size and forecast, by Technique
8.3.6.6.4. Market size and forecast, by Application
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product Type
8.4.6.1.3. Market size and forecast, by Technique
8.4.6.1.4. Market size and forecast, by Application
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. Japan
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product Type
8.4.6.2.3. Market size and forecast, by Technique
8.4.6.2.4. Market size and forecast, by Application
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product Type
8.4.6.3.3. Market size and forecast, by Technique
8.4.6.3.4. Market size and forecast, by Application
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product Type
8.4.6.4.3. Market size and forecast, by Technique
8.4.6.4.4. Market size and forecast, by Application
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product Type
8.4.6.5.3. Market size and forecast, by Technique
8.4.6.5.4. Market size and forecast, by Application
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product Type
8.4.6.6.3. Market size and forecast, by Technique
8.4.6.6.4. Market size and forecast, by Application
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product Type
8.5.6.1.3. Market size and forecast, by Technique
8.5.6.1.4. Market size and forecast, by Application
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product Type
8.5.6.2.3. Market size and forecast, by Technique
8.5.6.2.4. Market size and forecast, by Application
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product Type
8.5.6.3.3. Market size and forecast, by Technique
8.5.6.3.4. Market size and forecast, by Application
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product Type
8.5.6.4.3. Market size and forecast, by Technique
8.5.6.4.4. Market size and forecast, by Application
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Argon Medical Devices, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.2. Eckert & Ziegler BEBIG
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Elekta AB
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. iCAD, Inc.
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. isoray medical, inc.
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Merit Medical Systems, Inc.
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Theragenics Corporation
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.8. Siemens AG
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. IsoAid
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Carl Zeiss AG
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance

LIST OF TABLES
TABLE 01. GLOBAL BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 02. BRACHYTHERAPY MARKET FOR SEEDS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. BRACHYTHERAPY MARKET FOR APPLICATORS AND AFTERLOADERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 04. BRACHYTHERAPY MARKET FOR ELECTRONIC BRACHYTHERAPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 05. GLOBAL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 06. BRACHYTHERAPY MARKET FOR HIGH DOSE RATE (HDR), BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. BRACHYTHERAPY MARKET FOR LOW DOSE RATE (LDR), BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 08. GLOBAL BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 09. BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. BRACHYTHERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. GLOBAL BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 14. BRACHYTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. BRACHYTHERAPY MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 16. BRACHYTHERAPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. BRACHYTHERAPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 18. NORTH AMERICA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 26. U.S. BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 29. CANADA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 30. CANADA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. MEXICO BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. MEXICO BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 34. MEXICO BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. EUROPE BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. EUROPE BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 38. EUROPE BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. EUROPE BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 40. GERMANY BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 41. GERMANY BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 42. GERMANY BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 43. GERMANY BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 44. FRANCE BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. FRANCE BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. FRANCE BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 47. FRANCE BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. UK BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. UK BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. UK BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 51. UK BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. ITALY BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. ITALY BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ITALY BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ITALY BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. SPAIN BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 57. SPAIN BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. SPAIN BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 59. SPAIN BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 60. REST OF EUROPE BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 61. REST OF EUROPE BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. REST OF EUROPE BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 63. REST OF EUROPE BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 66. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 67. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 68. ASIA-PACIFIC BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 69. CHINA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 70. CHINA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. CHINA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 72. CHINA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 73. JAPAN BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. JAPAN BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. JAPAN BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 76. JAPAN BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 77. INDIA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. INDIA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 79. INDIA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 80. INDIA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. AUSTRALIA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 82. AUSTRALIA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 83. AUSTRALIA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 84. AUSTRALIA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SOUTH KOREA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH KOREA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH KOREA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH KOREA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 92. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 93. LAMEA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 94. LAMEA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 95. LAMEA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 96. LAMEA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 97. LAMEA BRACHYTHERAPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 98. BRAZIL BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 99. BRAZIL BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 100. BRAZIL BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 101. BRAZIL BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 102. SAUDI ARABIA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 103. SAUDI ARABIA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 104. SAUDI ARABIA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 105. SAUDI ARABIA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 106. SOUTH AFRICA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 107. SOUTH AFRICA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 108. SOUTH AFRICA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 109. SOUTH AFRICA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 110. REST OF LAMEA BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 111. REST OF LAMEA BRACHYTHERAPY MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 112. REST OF LAMEA BRACHYTHERAPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 113. REST OF LAMEA BRACHYTHERAPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 114. ARGON MEDICAL DEVICES, INC.: KEY EXECUTIVES
TABLE 115. ARGON MEDICAL DEVICES, INC.: COMPANY SNAPSHOT
TABLE 116. ARGON MEDICAL DEVICES, INC.: PRODUCT SEGMENTS
TABLE 117. ARGON MEDICAL DEVICES, INC.: PRODUCT PORTFOLIO
TABLE 118. ECKERT & ZIEGLER BEBIG: KEY EXECUTIVES
TABLE 119. ECKERT & ZIEGLER BEBIG: COMPANY SNAPSHOT
TABLE 120. ECKERT & ZIEGLER BEBIG: PRODUCT SEGMENTS
TABLE 121. ECKERT & ZIEGLER BEBIG: PRODUCT PORTFOLIO
TABLE 122. ELEKTA AB: KEY EXECUTIVES
TABLE 123. ELEKTA AB: COMPANY SNAPSHOT
TABLE 124. ELEKTA AB: PRODUCT SEGMENTS
TABLE 125. ELEKTA AB: PRODUCT PORTFOLIO
TABLE 126. ICAD, INC.: KEY EXECUTIVES
TABLE 127. ICAD, INC.: COMPANY SNAPSHOT
TABLE 128. ICAD, INC.: PRODUCT SEGMENTS
TABLE 129. ICAD, INC.: PRODUCT PORTFOLIO
TABLE 130. ISORAY MEDICAL, INC.: KEY EXECUTIVES
TABLE 131. ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 132. ISORAY MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 133. ISORAY MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 134. ISORAY MEDICAL, INC.: KEY STRATERGIES
TABLE 135. MERIT MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
TABLE 136. MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
TABLE 137. MERIT MEDICAL SYSTEMS, INC.: PRODUCT SEGMENTS
TABLE 138. MERIT MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
TABLE 139. THERAGENICS CORPORATION: KEY EXECUTIVES
TABLE 140. THERAGENICS CORPORATION: COMPANY SNAPSHOT
TABLE 141. THERAGENICS CORPORATION: PRODUCT SEGMENTS
TABLE 142. THERAGENICS CORPORATION: PRODUCT PORTFOLIO
TABLE 143. SIEMENS AG: KEY EXECUTIVES
TABLE 144. SIEMENS AG: COMPANY SNAPSHOT
TABLE 145. SIEMENS AG: PRODUCT SEGMENTS
TABLE 146. SIEMENS AG: PRODUCT PORTFOLIO
TABLE 147. SIEMENS AG: KEY STRATERGIES
TABLE 148. ISOAID: KEY EXECUTIVES
TABLE 149. ISOAID: COMPANY SNAPSHOT
TABLE 150. ISOAID: PRODUCT SEGMENTS
TABLE 151. ISOAID: PRODUCT PORTFOLIO
TABLE 152. CARL ZEISS AG: KEY EXECUTIVES
TABLE 153. CARL ZEISS AG: COMPANY SNAPSHOT
TABLE 154. CARL ZEISS AG: PRODUCT SEGMENTS
TABLE 155. CARL ZEISS AG: PRODUCT PORTFOLIO

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • C型肝炎検査のグローバル市場（2021〜2031）：イムノアッセイ、PCR、その他技術
  • 医療機器洗浄のグローバル市場（2021-2031）：クリティカル、セミクリティカル、ノンクリティカル
  • マイクロバイオームシーケンスのグローバル市場（2021〜2031）：ショットガンシーケンス、RNAシーケンス、標的遺伝子シーケンス、全ゲノムシーケンス、その他
  • 衝撃波治療のグローバル市場（2021〜2031）：電気油圧技術、圧電技術、ラジアル技術、電磁衝撃波
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MA105 )"組織内照射療法のグローバル市場（2021〜2031）：シード、アプリケータ・アフターローダー、電気式組織内照射療法" (英文：Brachytherapy Market By Product Type (Seeds, Applicators and Afterloaders, Electronic Brachytherapy), By Technique (High Dose Rate (HDR), Low Dose Rate (LDR)), By Application (Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。